Skip to main content
logo
Biogen Pharmachem Industries Limited (BOM:531752)
India flag India · Delayed Price · Currency is INR
0.2900
-0.0100 (-3.33%)
At close: Jul 31, 2026

BOM:531752 Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
3.2220.160.171.290.83
Cash & Short-Term Investments
3.2220.160.171.290.83
Cash Growth
-84.05%11830.77%-86.87%54.69%1018.46%
Other Receivables
-5.67--18.4
Receivables
-5.67--18.4
Other Current Assets
1.650.850.750.250.11
Total Current Assets
4.8726.690.921.5419.34
Long-Term Investments
327.82238.4454.4388.5369.53
Other Long-Term Assets
-0-0---
Total Assets
993.99920.18568.22548.28549.5

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Other Current Liabilities
2.150.93.022.388.15
Total Current Liabilities
2.150.93.022.388.15
Long-Term Deferred Tax Liabilities
0.97----
Total Liabilities
3.120.93.022.388.15

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
902.6652.6652.6652.6652.6
Retained Earnings
--90.33-87.4-106.71-111.26
Comprehensive Income & Other
88.27357---
Shareholders' Equity
990.87919.28565.2545.9541.34
Total Liabilities & Equity
993.99920.18568.22548.28549.5

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Cash (Debt)
3.2220.160.171.290.83
Net Cash Growth
-84.05%11830.77%-86.87%54.69%-
Net Cash Per Share
0.000.030.000.000.00
Filing Date Shares Outstanding
999.42761.37761.37761.37761.37
Total Common Shares Outstanding
999.42761.37761.37761.37761.37
Working Capital
2.7325.79-2.1-0.8411.19
Book Value Per Share
0.991.210.740.720.71
Tangible Book Value
990.87919.28565.2545.9541.34
Tangible Book Value Per Share
0.991.210.740.720.71